☆ 4.5 Letter

Survival analysis of sentinel lymph node biopsy in rare malignant adnexal carcinomas

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2023)

Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients

Amrita Goyal et al.

Summary: The study analyzed the prognosis of cutaneous adnexal malignancies, survival relative to surgical management, and utility of lymph-node biopsy using data from the SEER-18 database. Results showed that narrow excisions had better 5-year DSS and OS compared to wide local excision. Lymph-node biopsy did not significantly impact survival in advanced stage disease, indicating limited utility.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Surgery

Malignant Cutaneous Adnexal Tumors and Role of SLNB

Alessandra Storino et al.

Summary: Malignant cutaneous adnexal tumors (MCATs) are rare skin tumors with generally low risk of lymphatic involvement, recurrence, and death, leading to excellent 5-year survival rates. Lymphatic disease after SLNB is rare in early-stage tumors, and the value of this staging procedure in MCAT remains unclear.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

添加到收藏夹

Review Dermatology